SPRY4 Antikörper (N-Term)
Kurzübersicht für SPRY4 Antikörper (N-Term) (ABIN347129)
Target
Alle SPRY4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with human 32 kDa Spry-4 protein
-
Kreuzreaktivität
- Maus, Rind (Kuh), Huhn
-
Kreuzreaktivität (Details)
- Cross reacts with mouse, bovine and chicken. Not tested on other species.
-
Aufreinigung
- Antiserum
-
Immunogen
- Synthetic peptide derived from N terminal region of Sprouty homolog 4 (Spry-4)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/100 to 1/500 - WB : 1/500 to 1/2 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- SPRY4 (Sprouty RTK Signaling Antagonist 4 (SPRY4))
-
Andere Bezeichnung
- SPRY4
-
Hintergrund
- Suppresses the insulin receptor and EGFR-transduced MAPK signaling pathway, but does not inhibit MAPK activation by a constitutively active mutant Ras. Probably impairs the formation of GTP-Ras. Inhibits Ras-independent, but not Ras-dependent, activation of RAF1.
-
UniProt
- Q9C004
Target
-